Jul 22, 2024, 23:10
Edgardo S. Santos: The ProPhet test could help us to tailor immunotherapy beyond just PD-L1 expression
Edgardo S. Santos, Vice President of Florida Society of Clinical Oncology, shared a post on X:
”Interesting data on a potential biomarker on how to decide between IO mono therapy vs. IO plus chemotherapy. The ProPhet test! It could help us to tailor immunotherapy beyond just PD-L1 expression.”
Source: Edgardo S. Santos/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 23, 2024, 14:32
Nov 23, 2024, 14:04
Nov 23, 2024, 13:58
Nov 23, 2024, 13:32